Lilly direct-selling Zepbound at $499/mo — compare with 11 other programs
Affiliate disclosure: we earn commission from some partners. Learn more.

REX MD alternatives: top 3 programs compared

If REX MD isn't right for you — coverage, pricing, state availability, or program fit — these are the editorially-vetted alternatives we recommend. Editorial pick at #1.

Last reviewed: June 2026 · how we rank · original REX MD review →

Editorial pick
Hims logo

Hims

from $13/mo
  • Best for cash-pay
  • Best for speed

Hims ED — generic sildenafil from $13/mo

Why we picked it

Generic sildenafil at roughly half the chewable-competitor per-dose cost, with branded Viagra/Cialis available if you want it.

Who should skip

Skip if you want fast-onset chewables — Hims uses standard tablets.

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • No chewable format
  • Subscription auto-renews — set a calendar reminder if unsure

We may earn a commission. Pricing on partner site is final.

Why we pick this: Highest-ranked REX MD alternative on our 5-factor methodology score.

Ro logo

Ro

from $2/mo
  • Best for clinical oversight

Ro — original online ED brand, sildenafil & tadalafil

Why we picked it

Cleaner clinical voice and quarterly auto-ship with reminders means less reorder friction once you've settled on a dose.

Who should skip

Skip if you want the lowest entry price — Hims undercuts Ro's starting tier.

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Entry price slightly above Hims
  • No chewable option

We may earn a commission. Pricing on partner site is final.

BlueChew logo

BlueChew

from $20/mo

BlueChew — chewable sildenafil & tadalafil

Off-Rx: no plan
Flaws but not dealbreakers (2)
  • Costs 2-5× more than generic sildenafil at competitors
  • Not available in New York

We may earn a commission. Pricing on partner site is final.

Why trust this comparison

Independent

No equity in any telehealth service. We earn affiliate commissions on click-through and never alter rankings for revenue.

Affiliate disclosure

Primary sources

Every clinical claim is cited to FDA labels, peer-reviewed trials with DOI links, or specialty-society guidelines. Never secondary sources.

Editorial methodology

Editorial-revenue separation

Commission rates do not affect ranking, scoring, or inclusion. We publish negative findings on paying affiliate partners.

Editorial policy

Compare REX MD head-to-head